AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
AbbVie will webcast a management fireside chat from the Morgan Stanley Global Healthcare Conference, with live and archived access for investors.
Rhea-AI Summary
AbbVie (ABBV) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, including a management fireside chat.
The discussion is scheduled for 9:00 a.m. Central time and will be available via live audio webcast on AbbVie’s Investor Relations website, with an archived replay accessible later that day.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel | Investors: Liz Shea |
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302868211.html
SOURCE AbbVie